[ 1 ] Xu L, Nevitt MC, Zhang Y, et al. High prevalence of knee, but not hip or hand ostetarthritis in Beijing elders:comprision with data of Caucasian in United States[J]. Nat Med J China, 2003, 83(14): l206-l209.
[2]
[ 2 ] Felson DT. Clinical practice--osteoarthritis of the knee[J]. N Engl J Med, 2006, 354(8): 841-848.
[3]
[ 3 ] Lanas A, Tornero J, Zamorano JL. Asessment of gastrointestinal and cardiaovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study[J]. Ann Rheum Dis, 2010, 69(8): 1453-1458.
[4]
[ 4 ] Oegema TR Jr, Deloria LB, Sandy JD, et al. Effect of oral glucosamine on cartilage and meniscus in normal and chymopapain-injected knees of young rabbits[J]. Arthritis Rheum, 2002, 46(9): 2495-2503.
[5]
[ 5 ] Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro[J]. Osteoarthritis Cartilage, 1998, 6(6): 427-434.
[6]
[ 6 ] Fenton JI, Chlebek-Brown KA, Peters TL, et al. Glucosamine HCl reduces equine articular cartilage degradation in explant culture[J]. Osteoarthritis Cartilage, 2000, 8(4): 258-265.
[7]
[ 7 ] Brief AA, Maurer SG, Di Cesare PE. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis[J]. J Am Acad Orthop Surg, 2001, 9(2): 71-78.
[8]
[ 8 ] Barr S, Bellamy N, Buchanan WW, et al. A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index[J]. J Rheumatol, 1994, 21(11): 2106-2112.
[9]
[ 9 ] Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee[J]. Arthritis Rheum, 1986, 29(8): l049-1039.
[10]
Lequesne MG, Samson M. Indices of severity in osteoarthritis for weight bearing joints[J]. J Rheumatol, 1991, 27: 16-18.
[11]
Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention[J]. Arthritis Rheum, 1998, 41(8): 1343-1355.
[12]
Wieland HA, Michaelis M, Kirschbaum BJ, et al. Osteoarthritis - an untreatable disease[J]. Nat Rev Drug Discov, 2005, 4(4): 331-344.
[13]
Bliddal H, Christensen RD, Kristensen PK, et al. Glucosamine effectiveness in the treatment of knee osteoarthritis. Presentation of a Cochrane analysis with the perspective on the GAIT trial[J]. Ugeskr Laeger, 2006, 168(50): 4405-4409.
[14]
Toda Y, Tsukimura N. A six-month followup of a randomized trial comparing the efficacy of a lateral-wedge insole with subtalar strapping and an in-shoe lateral-wedge insole in patients with varus deformity osteoarthritis of the knee[J]. Arthritis Rheum, 2004, 50(10): 3129-3136.
[15]
Mcalindon TE, Lavalley MP, Gulin JP, et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis[J]. JAMA, 2000, 283(11): 1469-1475.
